摘要
糖尿病肾病(DN)是糖尿病最常见的并发症之一,是终末期肾病(ESRD)的主要原因。炎症反应在DN的病理过程中起着关键作用。NLRP3作为研究最深入的炎症小体,在DN中不容忽视。其异常激活加速DN进程。在这篇综述中,我们总结了我们对NLRP3炎症小体的结构组成和激活因子的认识。此外,我们还将讨论NLRP3炎症小体激活之间的关系,以及NLRP3炎症小体作为DN治疗靶点的潜力。
关键词: NLRP3炎症小体,糖尿病肾病(DN),炎症,NLRP3结构,终末期肾病(ESRD), DN进展。
Current Medicinal Chemistry
Title:Targeting the NLRP3 Inflammasome in Diabetic Nephropathy
Volume: 28 Issue: 42
关键词: NLRP3炎症小体,糖尿病肾病(DN),炎症,NLRP3结构,终末期肾病(ESRD), DN进展。
摘要: Diabetic nephropathy (DN) is one of the most common complications of diabetes and the main cause of end-stage renal disease (ESRD). The inflammatory response plays a key role in the pathological process of DN. As the most deeply studied inflammasome, NLRP3 should not be overlooked in DN. Its abnormal activation accelerates DN progression. In this review, we summarize our understanding of the structural composition and activation factors of the NLRP3 inflammasome. Moreover, the relationship between NLRP3 inflammasome activation, and the potential of the NLRP3 inflammasome as a therapeutic target for DN will also be discussed.
Export Options
About this article
Cite this article as:
Targeting the NLRP3 Inflammasome in Diabetic Nephropathy, Current Medicinal Chemistry 2021; 28 (42) . https://dx.doi.org/10.2174/0929867328666210705153109
DOI https://dx.doi.org/10.2174/0929867328666210705153109 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?
Current Stem Cell Research & Therapy IgA Nephropathy: Clinical Significance of Urinary Proteins/Polypeptides Characterization
Current Proteomics Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes
Current Pharmaceutical Design Roles of Calcium and Tyrosine Kinases in the Pathogenesis of Type 2 Diabetes Mellitus
Current Enzyme Inhibition Role of Renin-Angiotensin-Aldosterone System in Metabolic Syndrome and Obesity-related Hypertension
Current Hypertension Reviews Collagen Receptors as Potential Targets for Novel Anti-Platelet Agents
Current Pharmaceutical Design Strategies for Non-Invasive Molecular Imaging of Acute Allograft Rejection by Gamma Scintigraphy and Positron Emission Tomography
Current Radiopharmaceuticals Treatment of IgG4-Related Disease
Current Immunology Reviews (Discontinued) Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Managing Comorbidity in COPD: A Difficult Task
Current Drug Targets Disorders of Sex Development: A Review
Current Women`s Health Reviews Abietane Diterpenes as Potential Candidates for the Management of Type 2 Diabetes
Current Pharmaceutical Design Homeobox Genes and Human Genetic Disorders
Current Molecular Medicine Modulators of Inhibitor of Growth (ING) Family Expression in Development and Disease
Current Drug Targets Can Dietary Polyphenols Prevent the Formation of Toxic Compounds from Maillard Reaction?
Current Drug Metabolism Thienocinnolinone Alkanoic Acid Derivatives as Aldose Reductase Inhibitors
Medicinal Chemistry Preventing Atherosclerosis with Angiotensin-Converting Enzyme Inhibitors: Emphasis on Diabetic Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders SAGE Application in the Study of Diabetes
Current Pharmaceutical Biotechnology The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection
Current HIV Research Combination of Daidzein, Hemin and Bms182874 Halts the Progression of Diabetes-Induced Experimental Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets